Earnings Feed
Start Free
Blueprint Medicines Corp·4

May 10, 4:05 PM ET

Landsittel Michael 4

4 · Blueprint Medicines Corp · Filed May 10, 2024

Insider Transaction Report

Form 4
Period: 2024-05-08
Blueprint Medicines CorpBPMC
Landsittel Michael
CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-05-08$8.80/sh+1,818$15,998→ 75,467 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-05-08+26,363→ 0 total
    Exercise: $1.87Exp: 2025-02-10→ Common Stock (26,363 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-05-08+1,818→ 0 total
    Exercise: $8.80Exp: 2024-10-08→ Common Stock (1,818 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-08$1.87/sh+26,363$49,299→ 73,649 total
Footnotes (3)
  • [F1]This transaction involved a cash exercise of options without a subsequent sale of the underlying shares of common stock.
  • [F2]The options were granted on February 10, 2015 and are fully vested as of the transaction date.
  • [F3]The options were granted on October 8, 2014 and are fully vested as of the transaction date.

Documents

2 files